{"nctId":"NCT01411501","briefTitle":"Efficacy and Safety of Acupuncture for Functional Constipation","startDateStruct":{"date":"2011-09"},"conditions":["Constipation"],"count":684,"armGroups":[{"label":"Acupuncture at ST25 and BL25","type":"EXPERIMENTAL","interventionNames":["Other: acupuncture"]},{"label":"Acupuncture at LI11 and ST37","type":"EXPERIMENTAL","interventionNames":["Other: acupuncture"]},{"label":"Acupuncture at ST25, BL25, LI11 and ST37","type":"EXPERIMENTAL","interventionNames":["Other: acupuncture"]},{"label":"medicine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: mosapride citrate"]}],"interventions":[{"name":"acupuncture","otherNames":["acupuncture and moxibustion"]},{"name":"mosapride citrate","otherNames":["mosapride citrate,made in China"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients who has been diagnosed with functional constipation according to Rome â…¢ criteria\n* Patients who are aged 18-75 years old\n* Stop medication or acupuncture (if any) 1 week before randomization and uninvolved in other trials\n* Sign the informed consent out of one's own will\n\nExclusion Criteria:\n\n* Secondary constipation\n* Patients with consciousness impairment, psychotic patients or patients unable to express clearly\n* Patients with malignant tumor in progressive stage, severe wasting disease and liable to be infected and bleed\n* Patients with severe cardiovascular disease, hepatic injury, renal damage, digestive disease or hematological diseases\n* Women in pregnancy and lactation period","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change of the SBMs From Baseline at Week 4","description":"\\[average number of spontaneous bowel movements in a week at week 4\\]-\\[average number of spontaneous bowel movements in a week at baseline\\]","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","spread":null},{"groupId":"OG001","value":"2.7","spread":null},{"groupId":"OG002","value":"2.2","spread":null},{"groupId":"OG003","value":"2.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in the Bristol Stool Scale at the 4th Week","description":"Bristol stool scale provides illustration of seven stool types. It ranges from 1 to 7 with the meaning that 1 referring to separate hard lumps and 7 referring to watery, no solid pieces. For patients with constipation, a higher score means a better outcome. This outcome means the Bristol Stool Scale at the 4th week-the Bristol Stool Scale at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.9","spread":null},{"groupId":"OG001","value":"3.9","spread":null},{"groupId":"OG002","value":"3.9","spread":null},{"groupId":"OG003","value":"3.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Difficulty Degree of Defecation at the 4th Week","description":"This outcome describes how much effort the patients with while defecating.It ranges from 0 to 3.\n\n0-Without difficulty\n\n1. Defecation straining\n2. Severe defecation straining\n3. Defecation with the help of hands, A 0 is considered better than 3 for outcome. Patients score for themselves according to their own feelings.\n\n\\[the average score of one week at the 4th week\\]-\\[the average score of one week at baseline\\]","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"41","spread":null},{"groupId":"OG002","value":"33","spread":null},{"groupId":"OG003","value":"36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69","spread":null},{"groupId":"OG001","value":"78","spread":null},{"groupId":"OG002","value":"76","spread":null},{"groupId":"OG003","value":"76","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"33","spread":null},{"groupId":"OG001","value":"36","spread":null},{"groupId":"OG002","value":"38","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null},{"groupId":"OG001","value":"12","spread":null},{"groupId":"OG002","value":"14","spread":null},{"groupId":"OG003","value":"9","spread":null}]}]}]},{"type":"SECONDARY","title":"Changes of the SBMs From Baseline at Week 8","description":"\\[average number of spontaneous bowel movements in a week at week 8\\]-\\[average number of spontaneous bowel movements in a week at baseline\\]","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":null},{"groupId":"OG001","value":"2.4","spread":null},{"groupId":"OG002","value":"2.1","spread":null},{"groupId":"OG003","value":"1.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in the Bristol Stool Scale at the 8th Week","description":"Bristol stool scale provides illustration of seven stool types. It ranges from 1 to 7 with the meaning that 1 referring to separate hard lumps and 7 referring to watery, no solid pieces. For patients with constipation, a higher score means a better outcome. This outcome means the Bristol Stool Scale at the 8th week-the Bristol Stool Scale at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":null},{"groupId":"OG001","value":"3.6","spread":null},{"groupId":"OG002","value":"3.4","spread":null},{"groupId":"OG003","value":"3.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Difficulty Degree of Defecation at the 8th Week","description":"This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3.\n\n0-Without difficulty\n\n1. Defecation straining\n2. Severe defecation straining\n3. Defecation with the help of hands, A 0 is considered better than 3 for outcome. Patients score for themselves according to their own feelings.\n\n\\[the average score of one week at the 8th week\\]-\\[the average score of one week at baseline\\]","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"45","spread":null},{"groupId":"OG001","value":"46","spread":null},{"groupId":"OG002","value":"40","spread":null},{"groupId":"OG003","value":"36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75","spread":null},{"groupId":"OG001","value":"88","spread":null},{"groupId":"OG002","value":"83","spread":null},{"groupId":"OG003","value":"67","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29","spread":null},{"groupId":"OG001","value":"25","spread":null},{"groupId":"OG002","value":"28","spread":null},{"groupId":"OG003","value":"44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"8","spread":null},{"groupId":"OG003","value":"16","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":168},"commonTop":["Common cold","Joint pains","Eye discomfort","Irregular menstruation","Fundus hemorrhage"]}}}